Abstract
Accurate staging is of paramount importance for the decision-making process. Positron emission tomography has been used increasingly for staging and follow-up of patients with head and neck cancer Patient preference, physician expertise, and toxicity issues are important factors when determining clinical management for individuals. Surgical treatment remains superior to conservative treatment in reference to disease control, but the latter is superior in terms of organ preservation. External radiotherapy alone and/or brachytherapy may offer an excellent outcome in early-stage disease. Altered fractionation radiotherapy and concomitant chemoradiation have resulted in improved locoregional control of locally advanced disease. For locally advanced disease, concomitant chemoradiation appears to confer a reproducible survival benefit; the optimal time-dose regimen has not yet been defined for this approach. Altered fractionation radiotherapy and chemoradiation increase acute toxicity profile. Concomitant chemoradiotherapy should be the gold standard after resection in patients at high risk of failure or for patients not suitable for chemotherapy. Targeted chemoradiotherapy with monoclonal antibodies appears to be a promising approach, with a high therapeutic index
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alonso JM (1950) La Chirurgie Conservatrice pour le Cancer du Larynx at de l’ Hypopharynx. Ann. Otolaryngol.(Paris) 67:567-575
Al-Sarraf M (2002) Treatment of locally advanced head and neck cancer: historical and critical review. Cancer Control 9:387-399
Andrea M (1995) Contact endoscopy during microlaryngeal surgery: a new technique for endoscopic examination of the larynx. Ann Otol Rhinol Laryngol 104(5):333-339
Ang KK, Berkey BA, Tu X, et al (2002) Impact of epidermal growth factor receptor overexpression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62:7350-7356
Antognoni P, Corvò R, Zerini D, Orecchia R (2005) Altered fractionation radiotherapy in head and neck cancer: clinical issues and pitfalls of ‘‘evidence-based medicine’’. Tumori 91:30-39
Arens C, Reussner D, Neubacher H, Woenckhaus J, Glanz H (2006) Spectrometric measurement in laryngeal cancer Eur Arch Otorhinolaryngol 263:1001-1007.
Armstrong W, Ridgway J (2006) Optical coherence tomography of laryngeal cancer. Laryngoscope 116(7):1107-1113
Baletic N, Petrovic Z, Pendjer I, Malicevic H (2004) Autofluorescent diagnostics in laryngeal pathology. Eur Arch Otorhinolaryngol 261:233-237
Barton RT (1973) Surgical treatment of carcinoma of the pyriform sinus. Arch Otolaryngol 97:337-339
Barzan L, Comoretto R (1993) Hemipharyngectomy and hemilaryngectomy for pyriform sinus cancer: reconstruction with remaining larynx and hypopharynx and with tracheostomy. Laryngoscope 103:82-86
Baumann M, Krause M (2004) Targeting the epidermal growth factor receptor in radiotherapy: radiobiological mechanisms, preclinical and clinical results. Radiother Oncol 72:257-266
Beauvillain C, Mahe M, Bourdin S, et al (1997) Final results of a randomized trial comparing chemotherapy plus radiotherapy with chemotherapy plus surgery plus radiotherapy in locally advanced resectable hypopharyngeal carcinomas. Laryngoscope 107:648-653
Becker N, Altenburg HP, Stegmaier C, Ziegler H (2007) Report on trends of incidence (1970-2002) of and mortality (1952-2002) from cancer in Germany. J Cancer Res Clin Oncol 133:23-35
Bentzen SM, Atasoy BM, Daley F, et al (2005) Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. J Clin Oncol 23:5560-5567
Bernier J (2004) Chemoradiation in locally advanced head and neck cancer: new evidence, new challenges. Expert Rev Anticancer Ther 4:335-339
Bernier J, Bentzen SM (2006) Radiotherapy for head and neck cancer: latest developments and future perspectives. Curr Opin Oncol 18:240-246
Biel MA (1994) Photodynamic therapy and the treatment of neoplastic diseases of the larynx. Laryngoscope 104:399-403
Biel MA (20020 Photodynamic therapy in head and neck cancer. Curr Oncol Rep 4:87-96
Blot WJ, Devesa SS, McLaughlin JK, Fraumeni JR JF (1994) Oral and pharyngeal cancers. Cancer Surv 19/20:23-42
Bonner JA, Harari PM, Giralt J, et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567-578
Bourhis J, Amand C, Pignon JP (2004) Update of MACH.NC (Meta-analysis of chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy. Proc Am Soc Clin Oncol 22-488
Bourhis J, Etessami A, Wilbault P, et al (2004) Altered fractionated radiotherapy in the management of head and neck carcinomas: advantages and limitations. Curr Opin Oncol 16:215-219
Bourhis J, Overgaard J, Audry H, et al (2006) Hyperfractionated or accelerated radiotherapy in head and neck cancer:a metaanalysis. Lancet 368:843-854
Bradford CR, Zhu S, Wolf GT, et al (1995) Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Otolaryngol Head Neck Surg 113:408-412
Bradford CR, Wolf GT, Carey TE, et al (1999) Predictive markers for response to chemotherapy, organ preservation, and survival in patients with advanced laryngeal carcinoma. Otolaryngol Head Neck Surg 121:534-538
Budach W, Her T, Budach V, Belka C, Dietz K (2006) A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer 6:28
Burch JD, Howe GR, Miller AB, Semenciw R (1981) Tobacco, alcohol, asbestos, and nickel in the etiology of cancer of the larynx: a case-control study. J Natl Cancer Inst 67:1219-1224
Corvò R (2007) Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiother Oncol 85:156-170
Davies L, Welch G (2006) Epidemiology of head and neck cancer in the United States Otolaryngol Head Neck Surg 135:451-457
Decker D, Drelichman A, Jacobs J, et al (1982) Adjuvant chemotherapy with high dose boluscis -diamminodichloroplatinum II (CDD) and 120 hour infusion 5-fluorouracil (5-FU) in stage III and IV squamous cell carcinoma of the head and neck. ASCO annual meeting, Saint Louis:abstr C-757
Decker DA, Drelichman A, Jacobs J, et al (1983) Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in stage III and IV squamous cell carcinoma of the head and neck. Cancer 51:1353-1355
DeSanto LW (1982) Current concept in otolaryngology:the options in early laryngeal carcinoma. N Engl J Med 306:910
Dische S, Saunders M, Barrett A, et al (1997) A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 44:123-136
Ensley J, Jacobs J, Weaver A, et al (1982) Initial cis-platinum combination predicting response to radiotherapy in patients with advanced epidermoid cancers of the head and neck. ASCO annual meeting, Saint Louis:abstr C-767
Ensley JF, Jacobs JR, Weaver A, et al (1984) Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 54:811-814
Eriksen JG, Steiniche T, Overgaard J (2005) The influence of epidermal growth factor receptor and tumor differentiation on the response to accelerated radiotherapy of squamous cell carcinomas of the head and neck in the randomized DAHANCA 6 and 7 study. Radiother Oncol 74:93-100
Fu KK, Pajak TF, Trotti A, et al (2000) A radiation therapy oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas:first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7-16
Gandara DR, Lara PN, Golberg Z, et al (2002) Tirapazamine:the prototype for a novel class of therapeutic agent targeting tumor hypoxia. Semin Oncol 29:102-109
Gregoire V, Eisbruch A, Hamoir M, Levendag P (2006) Proposal for the delineation of the nodal CTV in the node-positive and post-operative neck. Radiother Oncol 79:15-20
Gustavsson P, Jakobsson R, Johansson H, Lewin F, Norell S, Rutkvist LE. 1998 Occupational exposures and squamous cell carcinoma of the oral cavity, pharynx, larynx, and oesophagus: a case-control study in Sweden. Occup Environ Med 55:393-400
Hafidh MA, Lacy PD, Hughes JP, Duffy G, Timon CV. (2006) Evaluation of the impact of addition of PET to CT and MR scanning in the staging of patients with head and neck carcinomas Eur Arch Otorhinolaryngol 263:853-859
Harari PM (2005) Promising new advances in head and neck radiotherapy. Ann Oncol 16:vi13-9
Hirano M, Kurita S, Yoshida T et al (1988) Partial laryngopharyngectomy for pyriform sinus carcinoma. Technique and preliminary results. Auris Nasus Larynx 15:129-136
Hoffman H, Porter K, Karnell L, et al (2006) Laryngeal cancer in the Unites States:changes in demographics, patterns of care, and survival. Laryngoscope 116(9 Pt. 2 Suppl. 111):1-13
Iwai H., Koike Y., Nagahara K (1975) Subtotal pharyngolaryngectomy conservation surgery for carcinoma of sinus pyriformis extending toward the larynx. Arch. Oto-Rhino-Laryng 209:271-276
Kleinsasser O (1962) Die Laryngomikroskopie (Lupenlaryngoskopie) und ihre Bedeutung für die Erkennung der Vorerkrankungen und Fröhformen des Stimmlippenkarzinoms. Arch Ohren Nasen Kehlkopfheilkd 180:724-727
Laccourreye H, Laccourreye O, Weinstein G, et al 1990 Supracricoid laryngectomy with cricohyoidopexy: a partial laryngeal procedure for selected supraglottic and transglottic carcinomas. Laryngoscope 100:735-741
Laccourreye H, Laccourreye O, Weinstein G, et al (1990) Supracricoid laryngectomy with cricohyoidoepiglottopexy: a partial laryngeal procedure for glottic carcinoma. Ann Otol Rhinol Laryngol 99:421-426
Lammering G (2005) Molecular predictor and promising target:will EGFR now become a star in radiotherapy? Radiother Oncol 74:89-91
Laskar SG, Agarwal JP, Srinivas C, Dinshaw KA (2006) Radiotherapeutic management of locally advanced head and neck cancer. Expert Rev Anticancer Ther 6:405-417
Lawrence TS, Blackstock WA, McGinn C (2003) The mechanism of action of adiosensitization of conventional chemotherapeutic agents. Semin Radiat Oncol 13:13-21
Lee DJ (2002) Definitive radiotherapy for squamous carcinoma of the larynx. Otolaryngol Clin North Am 32:1013-1033
Lefebvre JL (2006) Laryngeal preservation in head and neck cancer:multidisciplinary approach. Lancet Oncol 7:747-755
Lefebvre JL, Chevalier D, Luboinski B, et al (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 88:890-899
Malzahn K, Dreyer T, Glanz H, Arens C (2002) Autofluorescence endoscopy in the diagnosis of early laryngeal cancer and its precursor lesions. Laryngoscope 112:488-493
Manyak MJ, Russo A, Smith PD, Glatscin E (1988) Photodynamic therapy. J Clin Oncol 6:380-391
Muylle K, Castaigne C, Flamen P (2005) 18F-fluoro-2-deoxy-D-glucose positron emission tomographic imaging: recent developments in head and neck cancer. Curr Opin Oncol 17(3):249-253
Ogura JH, Jurema AA, Watson RK (1960) Partial laryngopharyngectomy and neck dissection for pyriform sinus cancer. Conservation surgery with immediate reconstruction. Laryngoscope 22:737-747
Ogura JH, Mallen RW (1965) Partial laryngopharyngectomy for supraglottic and pharyngeal carcinoma. Tr Am Acad Ophthalmol Oto-Laryngol 69:832-845
Osman I, Sherman E, Singh B, et al (2002) Alteration of p53 pathway in squamous cell carcinoma of the head and neck:impact on treatment outcome in patients treated with larynx preservation intent. J Clin Oncol 20:2980-2987
Overgaard J, Hansen HS, Overgaard M, et al (1998) A randomized double-blind phase III study of nimorazole as hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results from the Danish Head and Neck Cancer Study (DAHANCA). Protocol 5-85. Radiother Oncol 46:135-146
Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J, Powell J (1992) Cancer incidence in five continents, vol VI. IARC Scientific Publications, Lyon
Parkin DM, Pisani P, Ferlay J (1999) Global cancer statistics. CA Cancer J Clin 49:33-64
Pfister D, Laurie SA, Weinstein GS, et al (2006) American Society of Clinical Oncology Practice Guidelines for the use of larynx preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24:3604-3693
Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma:three meta-analyses of updated individual data. Lancet 355:949-955
Porceddu SV, Jarmolowski E, Hicks RJ, et al (2005) Utility of positron emission tomography for the detection of disease in residual neck nodes after chemo-radiotherapy in head and neck cancer. Head Neck 27:175-181
Posner MR (2005) Paradigm shift in the treatment of head and neck cancer: the role of neoadjuvant chemotherapy. Oncologist 10:11-19
Richard JM, Sancho-Garnier H, Pessey JJ, et al (1998) Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 34:224-228
Ries LAG, Eisner MP, Kosary CL, et al (1973-1998) SEER Cancer Statistics Review. National Cancer Institute. Bethesda, MD
Roh JL, Pae KH et al (2007) 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx Eur J Surg Oncol 33(6):790-795
Rothman KJ, Cann CI, Flanders D, Fried MP (1980) Epidemiology of laryngeal cancer. Epidemiol Rev 2:195-209
Ryan WR, Fee Jr WE, Le QT, Pinto HA (2005) Positron-emission tomography for surveillance of head and neck cancer. Laryngoscope 115:645-650
Segas JV, Hantzakos AG, Tzagaroulakis AM, Adamapoulos GK (2001) A novel technique in the operative treatment of pyriform sinus carcinoma. Acta Otolaryngol 121(4):529-533
Schweitzer VG (2001) PHOTOFRIN-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies. Lasers Surg Med 29:305-313
Teknos TN, Cox C, Barrios MA, et al (2002) Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma. Laryngoscope 112:844-851
The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690
The Royal College of Surgeons of England, London (2000) Effective head & neck cancer management: Second consensus document. British Association of Otorhinolaryngologists, Head and Neck Surgeons, London
Trask DK, Wolf GT, Bradford CR, et al (2002) Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation. Laryngoscope 112:638-644
Tuyns AJ, Esteve J, Raymond L, et al (1988) Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). Int J Cancer 41:483-491
Wahlberg P, Andersson H, Biörklund A, Möller A (1998) Carcinoma of the hypopharynx: analysis of incidence and survival in Sweden over a 30-year period. Head Neck 20(8):714-719
Watanabe A, Taniguchi M, Tsujie H et al. (2009). The value of narrow band imaging for early detection of laryngeal cancer. Eur Arch Otorhinolaryngol 266(7):1017-1023
Weinstein GS, El-Sawy MM, Ruiz C, et al (2001) Laryngeal preservation with supracricoid partial laryngectomy results in improved quality of life when compared with total laryngectomy. Laryngoscope 111:191-199
Wenberger PM, Yu Z, Haffty BG, et al (2006) Molecular classification identifies a subset of human Papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 24:736-747
Wong RJ, Lin DT, Schoder H, et al (2002) Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 20:4199-4208
Wynder EL, Bross IJ, Feldman RM (1957) A study of etiological factors in cancer of the mouth. Cancer 10:1300-1323
Barnes L, Eveson JW, Reichart P, Sidransky D (eds.) (2005) World Health Organization Classification of Tumours. Pathology and genetics of head and neck tumours. IARC Press, Lyon
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hantzakos, A.G. (2009). Treatment Options for Laryngeal and Hypopharyngeal Cancer. In: Remacle, M., Eckel, H. (eds) Surgery of Larynx and Trachea. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79136-2_16
Download citation
DOI: https://doi.org/10.1007/978-3-540-79136-2_16
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-79135-5
Online ISBN: 978-3-540-79136-2
eBook Packages: MedicineMedicine (R0)